The Anti‐Cancer Stem Cell Properties of Copper(II)‐Terpyridine Complexes with Attached Salicylaldehyde Moieties
Open Access
- 11 November 2024
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 26 (2) , e202400703
Abstract
We report the synthesis, characterisation, and anti‐breast cancer stem cell (CSC) properties of two copper(II)‐terpyridine complexes with bidentate salicylaldehyde moieties (2‐hydroxybenzaldehyde for 1 and 2‐hydroxy‐1‐naphthaldehyde for 2). The copper(II)‐terpyridine complexes 1 and 2 are stable in biologically relevant aqueous solutions and display micromolar potency towards breast CSCs. The most effective complex 1 is 5‐fold and 6.6‐fold more potent towards breast CSCs than salinomycin and cisplatin, respectively. The copper(II)‐terpyridine complexes 1 and 2 also decrease the formation and viability of three‐dimensionally cultured mammospheres within the micromolar range. Notably complex 1 is up to 7‐fold more potent towards mammospheres than salinomycin or cisplatin. Mechanistic studies suggest that the copper(II)‐terpyridine complexes 1 and 2 are able to readily enter breast CSCs, elevate intracellular reactive oxygen species levels, induce DNA damage (presumably by oxidative DNA cleavage), and evoke apoptosis that is independent of caspases. This study shows that the copper(II)‐terpyridine motif is a useful building block for the design of anti‐breast CSC agents and reinforces the therapeutic potential of copper coordination complexes.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (EP/S005544/1)
- Engineering and Physical Sciences Research Council (EP/V034766/1)
- Engineering and Physical Sciences Research Council (EP/W02151X/1)
This publication has 45 references indexed in Scilit:
- The Therapeutic Potential in Cancer of Terpyridine‐Based Metal Complexes Featuring Group 11 ElementsChemMedChem, 2024
- Targeting chemotherapy-resistant tumour sub-populations using inorganic chemistry: Anti-cancer stem cell metal complexesCurrent Opinion in Chemical Biology, 2022
- Emerging Metallopharmaceuticals for the Treatment of CancerTrends in Chemistry, 2021
- A Triangular Platinum(II) Multinuclear Complex with Cytotoxicity Towards Breast Cancer Stem CellsAngewandte Chemie International Edition, 2019
- The Next Generation of Anticancer Metallopharmaceuticals: Cancer Stem Cell‐Active InorganicsChemBioChem, 2018
- Interactions of copper complexes with nucleic acidsCoordination Chemistry Reviews, 2018
- Activation of apoptosis signalling pathways by reactive oxygen speciesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Breast Cancer Stem Cell Potent Copper(II)–Non‐Steroidal Anti‐Inflammatory Drug ComplexesAngewandte Chemie International Edition, 2016
- Syntheses and Structures of Coordination Polymers Constructed by Semi‐Rigid Bicarboxylic Acid LigandsZeitschrift für anorganische und allgemeine Chemie, 2014
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput ScreeningCell, 2009